AL58805
/ Advenchen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 18, 2025
A Study of AL58805 in Patients With Advanced Tumors
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Advenchen Laboratories Nanjing Ltd.
New P1 trial
1 to 1
Of
1
Go to page
1